Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | 621,402 | reported | 18 May 2026 | tx 21+1,327,535−330,818 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 115,541 | 0.00 USD | |
| 02 Mar 2026 | TAX_WITHHOLDING | Aurinia Pharmaceuticals Inc. | 36,525 | 14.21 USD | |
| 27 Feb 2026 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 59,090 | 0.00 USD | |
| 27 Feb 2026 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 98,813 | 0.00 USD | deriv |
| 20 Feb 2026 | TAX_WITHHOLDING | Aurinia Pharmaceuticals Inc. | 34,638 | 14.40 USD | |
| 02 Jan 2026 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 48,558 | 0.00 USD | |
| 02 Jan 2026 | TAX_WITHHOLDING | Aurinia Pharmaceuticals Inc. | 40,385 | 15.95 USD | |
| 04 Mar 2025 | SALE | Aurinia Pharmaceuticals Inc. | 57,607 | 7.92 USD | |
| 03 Mar 2025 | SALE | Aurinia Pharmaceuticals Inc. | 64,872 | 8.00 USD | |
| 03 Mar 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 102,406 | 0.00 USD | |
| 28 Feb 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 84,106 | 0.00 USD | |
| 28 Feb 2025 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 128,438 | 0.00 USD | deriv |
| 06 Mar 2024 | SALE | Aurinia Pharmaceuticals Inc. | 57,745 | 5.60 USD | |
| 20 Feb 2024 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 194,230 | 0.00 USD | |
| 02 Mar 2023 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 204,810 | — | |
| 02 Mar 2023 | SALE | Aurinia Pharmaceuticals Inc. | 19,402 | 8.94 USD | |
| 02 Mar 2022 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 8,500 | 0.00 USD | |
| 02 Mar 2022 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 104,080 | 0.00 USD | deriv |
| 02 Mar 2022 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 178,063 | 0.00 USD | deriv |
| 28 Jan 2021 | PURCHASE | Aurinia Pharmaceuticals Inc. | 900 | 16.14 USD |